{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T07:50:59Z","timestamp":1773733859228,"version":"3.50.1"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Gastroenterol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Alcoholic liver disease (ALD) is a major global cause of liver-related morbidity and mortality, driven by excessive alcohol consumption and characterized by oxidative stress, inflammation, disordered lipid metabolism, and gut\u2013liver axis dysfunction. Oyster-derived bioactive compounds have shown hepatoprotective potential in experimental settings; however, their efficacy and role in ALD management remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To systematically evaluate and synthesize preclinical and clinical evidence on oyster-derived bioactive compounds for the prevention and treatment of ALD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PubMed, Web of Science, and Scopus were searched for studies examining oyster-derived bioactives, including polysaccharides, peptides, protein hydrolysates, and related extracts, in alcohol-induced liver injury models. Two reviewers independently screened studies and extracted data. Risk of bias was assessed using the SYRCLE tool for animal studies and RoB 2.0 for human trials. Certainty of evidence was evaluated using the GRADE framework.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Eleven studies met the inclusion criteria, comprising ten animal studies and one randomized controlled trial. In animal models, oyster-derived interventions reduced alanine and aspartate aminotransferase levels by approximately 34-56%, increased antioxidant defenses (glutathione and superoxide dismutase increased by up to 45% and 40%, respectively), and decreased inflammatory mediators including TNF-\u03b1, IL-1\u03b2, and IL-6. Improvements in lipid metabolism and gut\u2013liver axis markers were also reported in several studies. The single human trial demonstrated a modest reduction in \u03b3-glutamyl transferase, with no significant changes in ALT or AST. Overall, the certainty of evidence ranged from very low to low, reflecting methodological heterogeneity, risk of bias, and limited human data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Oyster-derived bioactives consistently demonstrate hepatoprotective effects in preclinical models of ALD through antioxidant, anti-inflammatory, metabolic, and gut-mediated mechanisms. However, the current evidence base is preliminary, and well-designed, adequately powered clinical trials are required to determine their clinical efficacy, optimal formulation, and long-term safety.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD420251104584<\/jats:ext-link>\n                      , identifier CRD420251104584.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fgstr.2026.1737942","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T05:26:35Z","timestamp":1773725195000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Hepatoprotective effects of oyster-derived bioactive compounds in alcoholic liver disease: a systematic review"],"prefix":"10.3389","volume":"5","author":[{"given":"Rui","family":"Chen","sequence":"first","affiliation":[{"name":"Clinical Nutrition Department, Yantaishan Hospital","place":["Yantai, Shandong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanan","family":"Qin","sequence":"additional","affiliation":[{"name":"Women\u2019s Health Department, Zhaoyuan Maternal and Child Health Hospital","place":["Yantai, Shandong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Yu","sequence":"additional","affiliation":[{"name":"Clinical Nutrition Department, Yantaishan Hospital","place":["Yantai, Shandong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/acer.15516","article-title":"Increased mortality from alcohol use disorder, alcohol-associated liver disease, and liver cancer from alcohol among older adults in the United States: 2000 to 2021","volume":"49","author":"Danpanichkul","year":"2025","journal-title":"Alcohol Clin Exp Res"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22105170","article-title":"Alcohol-related liver disease: basic mechanisms and clinical perspectives","volume":"22","author":"Liu","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2024.06.007","article-title":"Alcohol and hepatocellular carcinoma","volume":"28","author":"Ha","year":"2024","journal-title":"Clin Liver Dis"},{"key":"B4","unstructured":"Alcohol-related liver disease. MSD Manual Professional Version. Reviewed May 2025\n          \n          \n            \n              Jackson\n              W\n            \n            \n              Nguyen\n              M\n            \n          \n          \n          2025"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1055\/a-2421-5658","article-title":"Mitochondria and alcohol-associated liver disease: pathogenic role and target for therapy","volume":"45","author":"Torres","year":"2025","journal-title":"Semin Liver Dis"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v12.i7.332","article-title":"Oxidative stress in alcohol-related liver disease","volume":"12","author":"Tan","year":"2020","journal-title":"World J Hepatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathmechdis-031521-030435","article-title":"Recent advances in understanding of pathogenesis of alcohol-associated liver disease","volume":"18","author":"Wu","year":"2023","journal-title":"Annu Rev Pathol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Effect of ethanol on lipid metabolism","volume":"70","author":"You","year":"2019","journal-title":"J Hepatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k2817","article-title":"Mortality due to cirrhosis and liver cancer in the United States, 1999\u20132016: observational study","volume":"362","author":"Tapper","year":"2018","journal-title":"BMJ"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158081","article-title":"Hepatoprotective effect of oyster peptide on alcohol-induced liver disease in mice","volume":"23","author":"Wang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B11","doi-asserted-by":"publisher","first-page":"408 (ASPET abstract)","DOI":"10.1124\/jpet.408.131198","article-title":"The effects of taurine on alcohol-associated liver disease are dose-dependent and associated with alterations of taurine-conjugated bile acids and FXR\u2013FGF15 signaling","volume":"389","author":"Pei","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s10068-021-00941-9","article-title":"In vivo protective effect against ethanol metabolism and liver injury of oyster (Crassostrea gigas) extracts obtained via subcritical water processing","volume":"30","author":"Lee","year":"2021","journal-title":"Food Sci Biotechnol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/foods13193082","article-title":"Impact of thermal processing on the structure, antioxidant properties and hypoglycemic activities of sweet potato polysaccharides","volume":"13","author":"Liu","year":"2024","journal-title":"Foods"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2015.2563","article-title":"Improvement of liver function by the administration of oyster extract as a dietary supplement to habitual alcohol drinkers: A pilot study","volume":"10","author":"Osaki","year":"2015","journal-title":"Exp Ther Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2021.04.050","article-title":"Mediation of the microbiome-gut axis by oyster (Crassostrea gigas) polysaccharides: A possible protective role in alcoholic liver injury","volume":"182","author":"Jiang","year":"2021","journal-title":"Int J Biol Macromol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2015.03.056","article-title":"Hepatoprotective effect of a polysaccharide from Crassostrea gigas on acute and chronic models of liver injury","volume":"78","author":"Shi","year":"2015","journal-title":"Int J Biol Macromol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s11802-014-2449-0","article-title":"Protective effects of oyster extract against hepatic tissue injury in alcoholic liver diseases","volume":"13","author":"Zhang","year":"2014","journal-title":"J Ocean Univ China"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2019.02.053","article-title":"Sulfated modification of the polysaccharides from Crassostrea gigas and their antioxidant and hepatoprotective activities through metabolomics analysis","volume":"129","author":"Zhao","year":"2019","journal-title":"Int J Biol Macromol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/fsn3.2847","article-title":"Oyster broth concentrate and its major component taurine alleviate acute alcohol-induced liver damage","volume":"10","author":"Siregar","year":"2022","journal-title":"Food Sci Nutr"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/ijfs.14983","article-title":"Oyster hydrolysate ameliorates ethanol diet-induced alcoholic fatty liver by regulating lipid metabolism in rats","volume":"56","author":"Byun","year":"2021","journal-title":"Int J Food Sci Technol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1039\/d2fo00660j","article-title":"Protective effects of oyster protein hydrolysates on alcohol-induced liver disease (ALD) in mice: based on the mechanism of anti-oxidative metabolism","volume":"13","author":"Gao","year":"2022","journal-title":"Food Funct"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodres.2022.111647","article-title":"Oyster protein hydrolysates alleviated chronic alcohol-induced liver injury in mice by regulating hepatic lipid metabolism and inflammation response","volume":"160","author":"Wang","year":"2022","journal-title":"Food Res Int"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.03.018","article-title":"EASL Clinical Practice Guidelines: Management of alcohol-related liver disease","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30866","article-title":"Diagnosis and treatment of alcohol-associated liver diseases: 2019 Practice Guidance from the American Association for the Study of Liver Diseases","volume":"71","author":"Crabb","year":"2020","journal-title":"Hepatology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3350\/cmh.2017.0027","article-title":"Role of liver transplantation in severe alcoholic hepatitis","volume":"24","author":"Daswani","year":"2018","journal-title":"Clin Mol Hepatol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.01.031","article-title":"AlcHepNet Investigators. Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis","volume":"80","author":"Gawrieh","year":"2024","journal-title":"J Hepatol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19092826","article-title":"AMPK activation reduces hepatic lipid content by increasing fat oxidation in vivo","volume":"19","author":"Foretz","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.fbio.2024.103749","article-title":"Anti-obesity effect of fucoidan from Laminaria japonica and its hydrothermal degradation product","volume":"58","author":"Lu","year":"2024","journal-title":"Food Biosci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijnurstu.2019.103422","article-title":"Management of hypertriglyceridemia","volume":"75","author":"Oh","year":"2007","journal-title":"Am Fam Phys"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1101214","article-title":"Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis","volume":"365","author":"Nguyen-Khac","year":"2011","journal-title":"N Engl J Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3350\/cmh.2020.0057","article-title":"Fecal microbiota transplantation in alcohol related liver diseases","volume":"26","author":"Shasthry","year":"2020","journal-title":"Clin Mol Hepatol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10091386","article-title":"Ellagic acid prevents binge alcohol-induced leaky gut and liver injury through inhibiting gut dysbiosis and oxidative stress","volume":"10","author":"Kim","year":"2021","journal-title":"Antioxidants"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjnut.2024.09.031","article-title":"Alginate oligosaccharides enhance gut microbiota and intestinal barrier function, alleviating host damage induced by deoxynivalenol in mice","volume":"154","author":"Mi","year":"2024","journal-title":"J Nutr"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.913842","article-title":"Gut microbiota-modulating agents in alcoholic liver disease: Links between host metabolism and gut microbiota","volume":"9","author":"Jung","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1274261","article-title":"Intestinal microbiome-targeted therapies improve liver function in alcohol-related liver disease by restoring bifidobacteria: a systematic review and meta-analysis","volume":"14","author":"Chi","year":"2024","journal-title":"Front Pharmacol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/nu16081174","article-title":"The role of oxidative stress in alcoholic fatty liver disease: A systematic review and meta-analysis of preclinical studies","volume":"16","author":"Rabelo","year":"2024","journal-title":"Nutrients"}],"container-title":["Frontiers in Gastroenterology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgstr.2026.1737942\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T05:26:38Z","timestamp":1773725198000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgstr.2026.1737942\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":36,"alternative-id":["10.3389\/fgstr.2026.1737942"],"URL":"https:\/\/doi.org\/10.3389\/fgstr.2026.1737942","relation":{},"ISSN":["2813-1169"],"issn-type":[{"value":"2813-1169","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"article-number":"1737942"}}